Join to access to all OVN content. Join for Free
The Future of MSL Roles: Skills and Competencies for Tomorrow’s Challenges
MSL skills future trends digital literacy AI in healthcare patient-centricity

The Future of MSL Roles: Skills and Competencies for Tomorrow’s Challenges


Share This Article


Summary

This week’s guest is Stephanie Otis, Vice President Global Medical Excellence at Ferring Pharmaceuticals discusses future trends in the MSL field including the skills and competencies that will be essential for success.

Key Points

  • Scientific acumen, storytelling, and relationship-building remain the fundamental core competencies for successful MSLs, even as the role evolves with new technologies and business acumen.
  • MSLs must develop technical skills and digital literacy to adapt to rapidly changing healthcare landscapes, incorporating emerging technologies like AI and machine learning.
  • Future-proofing an MSL career involves maintaining learning agility and demonstrating enterprise leadership while ensuring patient-centricity in every aspect of their work.

Click for Source
MSL skills, future trends, digital literacy, AI in healthcare, patient-centricity

Related Topics

Meet Our Innovation Partners

Loading partners...

You May Also Like

Press Release
Breaking Silos in Oncology Dr Ramin Farhood & Dr Kirk Shepard on Voices of Oncology
OVN Avatar Joe Pardavila sits down with Dr. Ramin Farhood and Dr. Kirk Shepard

Breaking Silos in Oncology Dr Ramin Farhood & Dr Kirk Shepard on Voices of Oncology

Podcast
The Struggle With KOL Access in Todays World
Partner Avatar MSL Talk: Tom Caravela, Carsten Schnatwinkel, Jeanna Cooper

The Struggle With KOL Access in Todays World

Podcast
Medical Affairs- So Far to Come... So Far to Go
Partner Avatar MSL Talk: Tom Caravela, Mandy Krumnow

Medical Affairs- So Far to Come... So Far to Go

Article
Does biomarker use in oncology improve clinical trial failure risk? A large-scale analysis
OVN Avatar Jayson L. Parker, Sebnem S. Kuzulugil, Kirill Pereverzev, Stephen Mac, Gilberto Lopes, Zain Shah, Ashini Weerasinghe, Daniel Rubinger, Adam Falconi, Ayse Bener, Bora Caglayan, Rohan Tangri, Nicholas Mitsakakis

Does biomarker use in oncology improve clinical trial failure risk? A large-scale analysis

Article
Assessment of Coverage in England of Cancer Drugs Qualifying for US Food and Drug Administration Accelerated Approval
OVN Avatar Avi Cherla, MSc; Huseyin Naci, MHS, PhD; Aaron S. Kesselheim, MD, JD, MPH; Bishal Gyawali, MD, PhD; Elias Mossialos, MD, PhD

Assessment of Coverage in England of Cancer Drugs Qualifying for US Food and Drug Administration Accelerated Approval

Article
Assessment of Food and Drug Administration- and European Medicines Agency-Approved Systemic Oncology Therapies and Clinically Meaningful Improvements in Quality of Life: A Systematic Review
OVN Avatar Vanessa Arciero, BS, Seanthel Delos Santos, Liza Koshy

Assessment of Food and Drug Administration- and European Medicines Agency-Approved Systemic Oncology Therapies and Clinically Meaningful Improvements in Quality of Life: A Systematic Review

Explore OVN